Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Five-Year Multicenter Cohort Study of Vaginal Microbiome and STIs Progression

10 november 2026 bijgewerkt door: Muxuan Chen, Shenzhen Maternity & Child Healthcare Hospital

A Five-Year Longitudinal Follow-Up Study on Vaginal Microbiome Characteristics and Their Association With Reproductive Tract STIs and Cervical Lesion Progression Based on a Multicenter Cohort

  1. To elucidate the long-term impact of vaginal microbiome and the dynamic trends of its characteristics across 5 years follow-up visits on the clinical outcomes of sexually transmitted infections (STIs).
  2. To determine the long-term effects of specific microbial infections (Up6, MH) and vaginal microbiome characteristics on the progression of STIs.

Studie Overzicht

Toestand

Nog niet aan het werven

Conditie

Gedetailleerde beschrijving

This multicenter, observational study is a 5-year longitudinal follow-up extending the CALM2004 cohort. It aims to enroll 7,574 women aged 18-60 to investigate the long-term impact of vaginal microbiome characteristics and sexually transmitted infections (STIs) on cervical lesion progression. By collecting vaginal secretions, and blood samples, the study will evaluate the 5-year cumulative incidence of CIN2+ and determine how specific microbial infections (e.g., Up6, MH) influence clinical outcomes, providing high-level evidence for cervical cancer prevention strategies.

Studietype

Observationeel

Inschrijving (Geschat)

7574

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studiecontact

Studie Locaties

    • Beijing Municipality
      • Beijing, Beijing Municipality, China
        • Peking University First Hospital
        • Contact:
          • Bingbing Xiao, Doctor
    • Fujian
      • Fuzhou, Fujian, China
        • Fujian Maternity and Child Health Hospital
    • Gansu
      • Lanzhou, Gansu, China
        • The First Hospital of Lanzhou University
        • Contact:
          • Haitao Yu, Doctor
      • Lanzhou, Gansu, China
        • Gansu Provincial Hospital
        • Contact:
          • Lianhua Wei, Doctor
    • Guangdong
      • Chaozhou, Guangdong, China
        • Chaozhou Central Hospital
        • Contact:
          • Fen lin, Doctor
      • Foshan, Guangdong, China
        • Guangdong Provincial Hospital of Integrated Traditional Chinese and Western Medicine
        • Contact:
          • Chaoxin Jiang, Doctor
      • Guangzhou, Guangdong, China
        • The First Affiliated Hospital, Sun Yat-sen University
        • Contact:
          • Bin Huang, Doctor
      • Guangzhou, Guangdong, China
        • Nanfang Hospital, Southern Medical University
        • Contact:
          • Dehua Sun, Doctor
      • Guangzhou, Guangdong, China
        • The Fifth Affiliated Hospital of Southern Medical University
        • Contact:
          • Xiaoyan Li, Doctor
      • Guangzhou, Guangdong, China
        • The First Affiliated Hospital of Guangzhou University of Chinese Medicine
        • Contact:
          • Yingchun Zhou, Doctor
      • Guangzhou, Guangdong, China
        • The Fifth Affiliated Hospital of Guangzhou Medical University
        • Contact:
          • Liang Peng, Doctor
      • Guangzhou, Guangdong, China
        • The Third Affiliated Hospital of Southern Medical University
        • Contact:
          • Xuefeng Wang, Doctor
      • Guangzhou, Guangdong, China
        • The Third Affiliated Hospital of Guangzhou University of Chinese Medicine
        • Contact:
          • Kewei Zhao, Doctor
      • Guangzhou, Guangdong, China
        • Zhujiang Hospital of Southern Medical University
      • Guangzhou, Guangdong, China
        • Guangzhou Baiyun District Taihe People's Hospital
      • Huizhou, Guangdong, China
        • Huizhou Municipal Central Hospital
        • Contact:
          • Xianjin Wu, Doctor
      • Shaoguan, Guangdong, China
        • Yuebei People's Hospital
        • Contact:
          • Pingsen Zhao, Doctor
      • Shenzhen, Guangdong, China, 518028
        • Shenzhen Maternity & Child Healthcare Hospital
        • Contact:
          • Yuting Dai
          • Telefoonnummer: 0755-82869849
      • Shenzhen, Guangdong, China
        • Luohu District People's Hospital
      • Shenzhen, Guangdong, China
        • Southern Medical University Shenzhen Hospital
        • Contact:
          • Hongwei Zhou, Doctor
      • Shenzhen, Guangdong, China
        • The Seventh Affiliated Hospital, Sun Yat-sen University
        • Contact:
          • Zhaofan Luo, Doctor
      • Zhongshan, Guangdong, China
        • Zhongshan Xiaolan People's Hospital
        • Contact:
          • Wandang Wang, Doctor
      • Zhuhai, Guangdong, China
        • Zhuhai Maternal and Child Health Hospital
    • Guangxi
      • Nanning, Guangxi, China
        • The First Affiliated Hospital of Guangxi Medical University
        • Contact:
          • Faquan Lin, Doctor
    • Guizhou
      • Guiyang, Guizhou, China
        • Affiliated Hospital of Guizhou Medical University
        • Contact:
          • Fan Lu, Doctor
      • Zunyi, Guizhou, China
        • Zunyi First People's Hospital
        • Contact:
          • Kaifeng Wu, Doctor
    • Hainan
      • Haikou, Hainan, China
        • Hainan General Hospital
        • Contact:
          • Bo Wang, Doctor
    • Heilongjiang
      • Mudanjiang, Heilongjiang, China
        • Hongqi Hospital Affiliated to Mudanjiang Medical University
        • Contact:
          • Chunxia Guo, Doctor
      • Qiqihar, Heilongjiang, China
        • Qiqihar First Hospital
    • Henan
      • Zhengzhou, Henan, China
        • Henan Provincial People's Hospital
        • Contact:
          • Jing Zhao, Doctor
    • Inner Mongolia
      • Hohhot, Inner Mongolia, China
        • Inner Mongolia Autonomous Region Maternal and Child Health Hospital
        • Contact:
          • Jing Sha, Doctor
    • Jiangsu
      • Lianyungang, Jiangsu, China
        • The Second People's Hospital of Lianyungang
        • Contact:
          • Wei Liang, Doctor
    • Jilin
      • Jilin City, Jilin, China
        • Jilin City Central Hospital
        • Contact:
          • Guijie Zhang, Doctor
    • Liaoning
      • Shenyang, Liaoning, China
        • The First Hospital of China Medical University
        • Contact:
          • Ruizhe Wang, Doctor
    • Ningxia
      • Yinchuan, Ningxia, China
        • General Hospital of Ningxia Medical University
        • Contact:
          • Feng Li, Doctor
    • Qinghai
      • Xining, Qinghai, China
        • Qinghai Red Cross Hospital
        • Contact:
          • Dengyun Ma, Doctor
    • Shandong
      • Jinan, Shandong, China
        • Jinan Central Hospital
        • Contact:
          • Shuyi Han, Doctor
      • Jinan, Shandong, China
        • Shandong Provincial Hospital
    • Shanghai Municipality
      • Shanghai, Shanghai Municipality, China
        • Shanghai East Hospital, Tongji University
        • Contact:
          • Jingxin Cheng, Doctor
    • Shanxi
      • Changzhi, Shanxi, China
        • Changzhi People's Hospital
        • Contact:
          • Guoxiang Zhang, Doctor
    • Sichuan
      • Dazhou, Sichuan, China
        • Dazhou Integrated Traditional Chinese and Western Medicine Hospital
        • Contact:
          • Xuesu He, Doctor
      • Luzhou, Sichuan, China
        • Affiliated Hospital of Southwest Medical University
        • Contact:
          • Jinbo Liu, Doctor
    • Tibet
      • Lhasa, Tibet, China
        • Tibet Autonomous Region People's Hospital

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

18 jaar tot 60 jaar (Volwassen)

Accepteert gezonde vrijwilligers

Ja

Geslachten die in aanmerking komen voor studie

Vrouw

Bemonsteringsmethode

Niet-waarschijnlijkheidssteekproef

Studie Bevolking

A total of 7,574 women aged 18-60 years who previously participated in the baseline of the CALM2004 multicenter cohort study will be recruited for this 5-year longitudinal follow-up. This is a multicenter study, and participants will be recruited through targeted invitations from the research team members. The study population consists of women with a broad spectrum of baseline vaginal microecological statuses and varying risks of STIs and cervical lesions.

Beschrijving

Inclusion Criteria:

  1. Female aged 18 to 60 years.
  2. Participants who previously participated in the baseline of the CALM2004 study.
  3. Volunteers who are recruited through targeted invitations and consent to participate in this study.

Exclusion Criteria:

  1. Pregnant women.
  2. Received treatment for reproductive tract infections or sexually transmitted infections (STIs) within the past month.
  3. Used broad-spectrum antibiotics, local genital probiotics, or vaginal suppositories within the past month.

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Observatiemodellen: COHORT
  • Tijdsperspectieven: PROSPECTIVE

Cohorten en interventies

Groep / Cohort
CALM2004 Follow-up Cohort

A total of 7,574 women aged 18-60 who previously participated in the CALM2004 baseline study will be enrolled for a 5-year longitudinal follow-up. Participants will undergo comprehensive assessments including questionnaires, vaginal secretion collection for metagenomic sequencing, cervical exfoliated cells for TCT and STI nucleic acid testing, and venous blood testing. No specific interventions will be administered.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Cumulative incidence of CIN2+ at 5 years
Tijdsspanne: 5 years

The incidence rate of histologically confirmed Cervical Intraepithelial Neoplasia grade 2 or 3 (CIN2/3) or invasive cervical cancer occurring for the first time during the follow-up period, among participants who had no cervical lesions or were <CIN2 at baseline

5 years

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
New incidence and progression rates of ASC-US+ cytological abnormalities
Tijdsspanne: 5 years

ASC-US+ new incidence: First occurrence of ASC-US or higher cytological abnormality during follow-up in participants with normal baseline cytology. ASC-US+ progression: First occurrence of LSIL/HSIL or higher cytological abnormality during follow-up in participants with baseline ASC-US. Cytology is evaluated according to the Bethesda System for Reporting Cervical Cytology.

5 years

Andere uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
HPV and STI incidence, clearance, and persistent/recurrent infection rates
Tijdsspanne: 5 years

HPV new infection: baseline negative, follow-up positive; HPV clearance: baseline positive, follow-up negative; HPV persistent infection: same genotype positive at both baseline and follow-up. STI new infection: baseline negative, follow-up positive; STI clearance: baseline positive, follow-up same genotype negative; STI recurrent infection: same genotype positive at both baseline and follow-up.

5 years

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Geschat)

20 december 2026

Primaire voltooiing (Geschat)

30 juni 2028

Studie voltooiing (Geschat)

30 december 2028

Studieregistratiedata

Eerst ingediend

10 november 2026

Eerst ingediend dat voldeed aan de QC-criteria

10 november 2026

Eerst geplaatst (Werkelijk)

17 november 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

17 november 2026

Laatste update ingediend die voldeed aan QC-criteria

10 november 2026

Laatst geverifieerd

1 november 2026

Meer informatie

Termen gerelateerd aan deze studie

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren